Search research articles
Contact Us
Filters
Showing results (321-330 of 335) with videos related to
Page
of 34
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 2015
γδ T Cells Shape Preimmune Peripheral B Cell Populations
Yafei Huang, Andrew Getahun, Ryan A Heiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2014
Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff
Renata Duchnowska, Jeff Sperinde, Ahmed Chenna, et al.
Physical Review Letters
|
April 15, 2017
Systematic Fuel Cavity Asymmetries in Directly Driven Inertial Confinement Fusion Implosions
R C Shah, B M Haines, F J Wysocki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer
Peter Schmid, Cynthia X Ma, Yeon Hee Park, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 2, 2020
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment
Jeroen W G Derksen, Graham W Warren, Karin Jordan, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Oncotarget
|
December 2, 2015
Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
Renata Duchnowska, Piotr J Wysocki, Konstanty Korski, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
October 17, 2015
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy
Gang Zhang, Dongwei Guo, Prasanta K Dash, et al.
Kardiologia Polska
|
February 20, 2018
[Coordinated heart failure care in Poland: towards optimal organisation of the health care system]
Jadwiga Nessler, Adam Kozierkiewicz, Andrzej Gackowski, et al.
Frontiers in Oncology
|
February 7, 2024
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
Magdalena Knetki-Wróblewska, Rafał Dziadziuszko, Tomasz Jankowski, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 335) with videos related to
Sort By:
Page
of 34
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 2015
γδ T Cells Shape Preimmune Peripheral B Cell Populations
Yafei Huang, Andrew Getahun, Ryan A Heiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2014
Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff
Renata Duchnowska, Jeff Sperinde, Ahmed Chenna, et al.
Physical Review Letters
|
April 15, 2017
Systematic Fuel Cavity Asymmetries in Directly Driven Inertial Confinement Fusion Implosions
R C Shah, B M Haines, F J Wysocki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2026
Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer
Peter Schmid, Cynthia X Ma, Yeon Hee Park, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 2, 2020
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment
Jeroen W G Derksen, Graham W Warren, Karin Jordan, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Oncotarget
|
December 2, 2015
Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
Renata Duchnowska, Piotr J Wysocki, Konstanty Korski, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
October 17, 2015
The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy
Gang Zhang, Dongwei Guo, Prasanta K Dash, et al.
Kardiologia Polska
|
February 20, 2018
[Coordinated heart failure care in Poland: towards optimal organisation of the health care system]
Jadwiga Nessler, Adam Kozierkiewicz, Andrzej Gackowski, et al.
Frontiers in Oncology
|
February 7, 2024
Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice
Magdalena Knetki-Wróblewska, Rafał Dziadziuszko, Tomasz Jankowski, et al.
Page
of 34